Skip to main navigation Skip to search Skip to main content

Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC

  • Sean M. Davidson
  • , Ioanna Andreadou
  • , Charalambos Antoniades
  • , Jozef Bartunek
  • , Cristina Basso
  • , Bianca J. J. M. Brundel
  • , Robert A. Byrne
  • , Gemma Chiva-Blanch
  • , Paula da Costa Martins
  • , Paul C. Evans
  • , Henrique Girão
  • , Zoltan Giricz
  • , Can Gollmann-Tepeköylü
  • , Tomasz Guzik
  • , Mariann Gyöngyösi
  • , Norbert Hübner
  • , Michael Joner
  • , Petra Kleinbongard
  • , Thomas Krieg
  • , Elisa Liehn
  • Rosalinda Madonna, Ange Maguy, Melanie Paillard, Maurizio Pesce, Steffen E. Petersen, Gabriele G. Schiattarella, Joost P. G. Sluijter, Sabine Steffens, Katrin Streckfuss-Bömeke, Matthias Thielmann, Art Tucker, Sophie van Linthout, William Wijns, Johann Wojta, Joseph C. Wu, Cinzia Perrino*
*Corresponding author for this work
  • University College London
  • National and Kapodistrian University of Athens
  • University of Oxford
  • OLV Hospital Aalst
  • University of Padua
  • Mater Private Healthcare Dublin
  • Royal College of Surgeons in Ireland
  • Open University of Catalonia
  • Hospital Clinic de Barcelona
  • Instituto de Salud Carlos III
  • Faculty of Sciences and Engineering
  • Maastricht University
  • Queen Mary University of London
  • University of Coimbra
  • Semmelweis University
  • Innsbruck Medical University
  • University of Edinburgh
  • Medical University of Vienna
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  • Charité – Universitätsmedizin Berlin
  • German Centre for Cardiovascular Research
  • Technical University of Munich
  • University of Duisburg-Essen
  • University of Cambridge
  • University of Southern Denmark
  • University of Pisa
  • University of Bern
  • Universite Claude Bernard Lyon 1
  • IRCCS Centro Cardiologico S.P.A. Fondazione Monzino - Milano
  • Polytechnic University of Turin
  • King Faisal Specialist Hospital and Research Centre
  • Barts Health NHS Trust
  • Health Data Research UK
  • Alan Turing Institute
  • University of Naples Federico II
  • Utrecht University
  • Ludwig Maximilian University of Munich
  • University of Würzburg
  • University of Göttingen
  • Berliner Institut für Gesundheitsforschung
  • University of Galway
  • Ludwig Boltzmann Institute
  • Stanford University

Research output: Contribution to journalReview articleAcademicpeer-review

141 Downloads (Pure)

Abstract

Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples—such as whole blood or fractions, valvular and vascular tissues, myocardium, pericardium, or human-derived cells—is essential for enhancing the translational relevance of cardiovascular research. For instance, myocardial tissue slices, which preserve crucial structural and functional characteristics of the human heart, can be used in vitro to examine drug responses. Human blood serves as a rich source of biomarkers, including extracellular vesicles, various types of RNA (miRNA, lncRNA, and circRNAs), circulating inflammatory cells, and endothelial colony-forming cells, facilitating detailed studies of cardiovascular diseases. Primary cardiomyocytes and vascular cells isolated from human tissues are invaluable for mechanistic investigations in vitro. In cases where these are unavailable, human induced pluripotent stem cells serve as effective substitutes, albeit with specific limitations. However, the use of human samples presents challenges such as ethical approvals, tissue procurement and storage, variability in patient genetics and treatment regimens, and the selection of appropriate control samples. Biobanks are central to the efficient use of these scarce and valuable resources. This scientific statement discusses opportunities to implement the use of human samples for cardiovascular research within specific clinical contexts, offers a practical framework for acquiring and utilizing different human materials, and presents examples of human sample applications for specific cardiovascular diseases, providing a valuable resource for clinicians, translational and basic scientists engaged in cardiovascular research.
Original languageEnglish
Pages (from-to)702-729
Number of pages28
JournalCardiovascular research
Volume121
Issue number5
DOIs
Publication statusPublished - 1 Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biobank
  • Biopsy
  • Blood
  • Cardiovascular
  • Cardiovascular disease
  • Human
  • Myocardium
  • Single-cell sequencing
  • Translational research
  • Valve
  • Vascular
  • iPSCs

Fingerprint

Dive into the research topics of 'Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC'. Together they form a unique fingerprint.

Cite this